Literature DB >> 25911050

Effectiveness of prolonged clopidogrel-based dual antiplatelet therapy after drug-eluting stent implantation: Evidence-based meta-analysis.

Changzhi Liu1, Mao Liu, Dezhu Chen, Haifeng Liu, Qianhua Jiang, Jianhai Lu, Liuer Zuo.   

Abstract

The use of drug-eluting stents (DESs) for patients with coronary artery disease is widespread. DESs have been associated with a lower rate of repeat revascularization, death, and myocardial infarction compared with bare metal stents. However, DESs can lead to a prothrombotic environment in the coronary arteries, resulting in a higher rate of thrombotic events. To counteract this, dual-antiplatelet therapy (DAPT) consisting of aspirin and clopidogrel is recommended. Currently, there are no clear guidelines on the duration of DAPT. We therefore conducted a meta-analysis to assess the effectiveness of prolonged DAPT after DES implantation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25911050     DOI: 10.1007/s00059-015-4304-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  25 in total

1.  Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006.

Authors:  Warren K Laskey; Clyde W Yancy; William H Maisel
Journal:  Circulation       Date:  2007-05-01       Impact factor: 29.690

Review 2.  Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects.

Authors:  Liu Mao; Chen Jian; Liu Changzhi; Huang Dan; Huang Suihua; Tang Wenyi; Wu Wei
Journal:  Arch Cardiovasc Dis       Date:  2013-09-27       Impact factor: 2.340

3.  A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation).

Authors:  Byeong-Keuk Kim; Myeong-Ki Hong; Dong-Ho Shin; Chung-Mo Nam; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Tae-Soo Kang; Byoung-Eun Park; Woong-Chol Kang; Seung-Hwan Lee; Jung-Han Yoon; Bum-Kee Hong; Hyuck-Moon Kwon; Yangsoo Jang
Journal:  J Am Coll Cardiol       Date:  2012-09-19       Impact factor: 24.094

4.  Beneficial impact of prolonged dual antiplatelet therapy after drug-eluting stent implantation.

Authors:  Gennaro Sardella; Massimo Mancone; Giuseppe Biondi-Zoccai; Giulia Conti; Emanuele Canali; Rocco Stio; Luigi Lucisano; Simone Calcagno; Carlotta de Carlo; Francesco Fedele
Journal:  J Interv Cardiol       Date:  2012-01-16       Impact factor: 2.279

5.  Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).

Authors:  Stephen D Wiviott; Elliott M Antman; C Michael Gibson; Gilles Montalescot; Jeffrey Riesmeyer; Govinda Weerakkody; Kenneth J Winters; Jeffrey W Warmke; Carolyn H McCabe; Eugene Braunwald
Journal:  Am Heart J       Date:  2006-10       Impact factor: 4.749

Review 6.  Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.

Authors:  Sammy Elmariah; Laura Mauri; Gheorghe Doros; Benjamin Z Galper; Kelly E O'Neill; Philippe Gabriel Steg; Dean J Kereiakes; Robert W Yeh
Journal:  Lancet       Date:  2014-11-16       Impact factor: 79.321

7.  Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.

Authors:  Hyeon-Cheol Gwon; Joo-Yong Hahn; Kyung Woo Park; Young Bin Song; In-Ho Chae; Do-Sun Lim; Kyoo-Rok Han; Jin-Ho Choi; Seung-Hyuk Choi; Hyun-Jae Kang; Bon-Kwon Koo; Taehoon Ahn; Jung-Han Yoon; Myung-Ho Jeong; Taek-Jong Hong; Woo-Young Chung; Young-Jin Choi; Seung-Ho Hur; Hyuck-Moon Kwon; Dong-Woon Jeon; Byung-Ok Kim; Si-Hoon Park; Nam-Ho Lee; Hui-Kyung Jeon; Yangsoo Jang; Hyo-Soo Kim
Journal:  Circulation       Date:  2011-12-16       Impact factor: 29.690

8.  Benefits and risks of long-term duration of dual antiplatelet therapy after drug-eluting stenting: a meta-analysis of randomized trials.

Authors:  Marco Valgimigli; Seung-Jung Park; Hyo-Soo Kim; Kyung Woo Park; Duk-Woo Park; Pierluigi Tricoci; Giuseppe Ferrante
Journal:  Int J Cardiol       Date:  2013-04-13       Impact factor: 4.164

9.  Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).

Authors:  Gaetano Tanzilli; Cesare Greco; Francesco Pelliccia; Vincenzo Pasceri; Francesco Barillà; Vincenzo Paravati; Gaetano Pannitteri; Carlo Gaudio; Enrico Mangieri
Journal:  Am J Cardiol       Date:  2009-09-26       Impact factor: 2.778

10.  Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments.

Authors:  Carson Ka-Lok Lo; Dominik Mertz; Mark Loeb
Journal:  BMC Med Res Methodol       Date:  2014-04-01       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.